PARTIAL ALLELOTYPE OF CARCINOMA IN-SITU OF THE HUMAN BLADDER

被引:0
|
作者
ROSIN, MP
CAIRNS, P
EPSTEIN, JI
SCHOENBERG, MP
SIDRANSKY, D
机构
[1] JOHNS HOPKINS UNIV,SCH MED,DEPT OTOLARYNGOL,DIV HEAD & NECK CANC RES,BALTIMORE,MD 21205
[2] JOHNS HOPKINS UNIV,SCH MED,DEPT PATHOL,BALTIMORE,MD 21205
[3] JOHNS HOPKINS UNIV,SCH MED,DEPT UROL,BALTIMORE,MD 21205
[4] SIMON FRASER UNIV,ENVIRONM CARCINOGENESIS LAB,BURNABY,BC V5A 1S6,CANADA
[5] BRITISH COLUMBIA CANC RES CTR,DIV EPIDEMIOL & CANC PREVENT,VANCOUVER,BC V5Z 1E6,CANADA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Carcinoma in situ (CIS) of the urinary bladder is an aggressive lesion that frequently progresses to an invasive tumor, yet the underlying molecular changes in this lesion are largely unknown. In this study, we microdissected 31 cases of CIS and examined them for loss of heterozygosity (LOH) on 13 chromosomal arms, Twenty-nine microsatellite markers mere chosen for this analysis based on their location in regions previously shown to be frequently lost in primary transitional cell carcinoma of the bladder, LOH of chromosome 9 was a frequent event in these samples, occurring in 77% of these lesions, with 19 of 31 cases showing deletion on the 9p arm (61%) and 17 of 28 cases displaying LOH on 9q (61%), Fine mapping at 9p21 demonstrated that CIS also displayed a high frequency of homozygous deletion surrounding the p16(INK4A) locus, like superficial papillary tumors, the other form of noninvasive lesion found in the bladder, However, loss of 14q (70%) was frequent in CIS yet extremely rare in papillary lesions (9%), Other chromosomal arms showing frequent LOH included 8p (65%), 17p (60%), 13q (56%), 11p (54%), and 4q (52%), whereas slightly lower frequencies of loss were observed for 11q (36%), 4p (32%), 3p (31%), 18q (29%), and 5q (20%), CIS lesions already possess many of the genetic alterations displayed by invasive transitional cell carcinomas, potentially accounting for the aggressive nature of these lesions.
引用
收藏
页码:5213 / 5216
页数:4
相关论文
共 50 条
  • [1] CARCINOMA IN-SITU OF THE BLADDER
    HUDSON, MA
    HERR, HW
    [J]. JOURNAL OF UROLOGY, 1995, 153 (03): : 564 - 572
  • [2] CARCINOMA IN-SITU OF BLADDER
    YATESBELL, AJ
    [J]. BRITISH JOURNAL OF SURGERY, 1971, 58 (05) : 359 - +
  • [3] IN-SITU CARCINOMA OF URINARY BLADDER
    KULATILAKE, AE
    CHISHOLM, GD
    OLSEN, EGJ
    [J]. PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1970, 63 (01): : 95 - +
  • [4] PLIGHT OF PATIENT WITH CARCINOMA IN-SITU OF BLADDER
    UTZ, DC
    HANASH, KA
    FARROW, GM
    [J]. JOURNAL OF UROLOGY, 1970, 103 (02): : 160 - &
  • [5] ALLELOTYPE OF HUMAN BLADDER-CANCER
    KNOWLES, MA
    ELDER, PA
    WILLIAMSON, M
    CAIRNS, JP
    SHAW, ME
    LAW, MG
    [J]. CANCER RESEARCH, 1994, 54 (02) : 531 - 538
  • [6] Partial allelotype of schistosomiasis-associated bladder cancer
    Shaw, ME
    Elder, PA
    Abbas, A
    Knowles, MA
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1999, 80 (05) : 656 - 661
  • [7] CARCINOMA IN-SITU OF BLADDER WITH ASSOCIATED PROSTATIC INVOLVEMENT
    THELMO, WL
    SEEMAYER, TA
    MADARNAS, P
    MOUNT, BMM
    MACKINNON, KJ
    [J]. JOURNAL OF UROLOGY, 1974, 111 (04): : 491 - 494
  • [8] CARCINOMA IN-SITU OF THE URINARY-BLADDER - CLUES TO HOST INVOLVEMENT IN HUMAN CARCINOGENESIS
    OROZCO, RE
    MARTIN, AA
    MURPHY, WM
    [J]. CANCER, 1994, 74 (01) : 115 - 122
  • [9] CARCINOMA IN-SITU OF URETER IN PATIENTS WITH BLADDER CARCINOMA TREATED BY CYSTECTOMY
    SHARMA, TC
    MELAMED, MR
    WHITMORE, WF
    [J]. CANCER, 1970, 26 (03) : 583 - &
  • [10] WHOLE BLADDER WALL PHOTODYNAMIC THERAPY FOR REFRACTORY CARCINOMA IN-SITU OF THE BLADDER
    UCHIBAYASHI, T
    KOSHIDA, K
    KUNIMI, K
    HISAZUMI, H
    [J]. BRITISH JOURNAL OF CANCER, 1995, 71 (03) : 625 - 628